TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein involved in tissue repair and cell migration. It is one of the most studied peptides for wound healing and regeneration research. Here we address the most common questions about TB-500 and the Peptides Pharma vial formulation.
TB-500 is a synthetic peptide consisting of the active region of Thymosin Beta-4, a 43-amino acid protein produced naturally by the thymus gland. It plays a role in actin regulation, cell migration, and new blood vessel formation. Peptides Pharma TB-500 is formulated at >99% purity with a 15 mg dose in a precision vial system.
TB-500 is thought to function primarily through the regulation of actin, a cell-building protein critical for cell movement and tissue repair. By sequestering actin monomers and promoting their polymerisation at wound sites, TB-500 may facilitate cell migration to damaged tissue, promote angiogenesis, and reduce inflammation.
TB-500 is studied in research related to wound healing, cardiac tissue repair, muscle injury recovery, corneal healing, hair regrowth, and neuroinflammation. Its ability to upregulate cell migration makes it a key compound in tissue regeneration and repair research.
Peptides Pharma TB-500 is delivered through a lyophilized vial containing 15 mg in 3 mL of solution. The vial is designed for subcutaneous injection with precise click-based dosing. No reconstitution is required, and the vial provides consistent delivery across the full 30-day dosing period.
Peptides Pharma TB-500 is manufactured to >99% purity in GMP-certified facilities with ISO 7 cleanroom standards. Each batch undergoes independent HPLC and mass spectrometry verification. Certificates of Analysis are available for every production batch.
TB-500 pens should be refrigerated at 2-8°C and protected from direct light. Do not freeze. Under proper storage conditions, Peptides Pharma TB-500 has a shelf life of 24 months.
TB-500 is commonly studied in combination with BPC-157 for tissue repair research. The two peptides are believed to work through complementary pathways — TB-500 via actin regulation and cell migration, BPC-157 via nitric oxide and growth factor modulation. This is for research reference only.
Each Peptides Pharma TB-500 vial is designed for a 30-day protocol. The 15 mg / 3 mL formulation provides consistent daily dosing throughout the entire period with no need for refills or reconstitution.
TB-500 refers to the synthetic active fragment of Thymosin Beta-4 (TB4), the full-length naturally occurring protein. TB-500 contains the key amino acid sequence responsible for the biological activity attributed to TB4, particularly the actin-binding domain.
TB-500 is legal to buy in the UK for research purposes. It is classified as a research chemical and is not a controlled substance. Peptides Pharma supplies TB-500 exclusively for laboratory and research use.
Answers to frequently asked questions about BPC-157 peptide research. Learn about purity, storage, administration, and research applications of Peptides Pharma BPC-157 vials.
10 questionsPRODUCTCommon CJC-1295 research questions answered. Learn about GHRH analogue mechanisms, GH stimulation, purity, dosing, and Peptides Pharma's lyophilized vial format.
10 questionsPRODUCTIpamorelin research FAQ. Learn about this selective growth hormone secretagogue, its mechanisms, research applications, purity, and Peptides Pharma's vial system.
10 questionsPRODUCTTirzepatide research FAQ. Learn about dual GIP/GLP-1 agonist mechanisms, metabolic research, purity, dosing, and Peptides Pharma's peptide vial system.
10 questionsPRODUCTGHK-Cu copper peptide FAQ. Learn about collagen synthesis, skin repair mechanisms, anti-aging research, purity, and Peptides Pharma's lyophilized vial format.
10 questionsPRODUCTGlutathione research FAQ. Learn about this master antioxidant, detoxification mechanisms, immune support research, purity, and Peptides Pharma's vial system.
10 questionsOur team is here to help. Contact us for expert guidance on peptide research.